Observing symptoms after thyroid surgery in cancer patients
A Prospective Multi-centered Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T) in Patients With Thyroid Cancer
This study looks at how patients with thyroid cancer feel and recover after thyroid surgery to see how well their symptoms are managed and what factors might affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Ilsan Cha hospital Academic / other |
| Locations | 3 sites (Gyeonggi-do and 2 other locations) |
| Trial ID | NCT06158360 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the safety and efficacy of postoperative management in patients with thyroid cancer who have undergone subtotal or total thyroidectomy. It involves a comprehensive analysis of the quality of life and symptoms experienced by these patients post-surgery. The study aims to assess the effectiveness and safety of treatments for postoperative symptoms and analyze prognostic factors related to disease-free and overall survival. Additionally, it seeks to establish a database for future research on cancer management.
Who should consider this trial
Good fit: Ideal candidates are adults aged 19 years or older diagnosed with thyroid cancer who have recently undergone thyroid surgery.
Not a fit: Patients with significant comorbidities or those requiring immediate surgical intervention may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance postoperative care and improve the quality of life for thyroid cancer patients.
How similar studies have performed: Other observational studies have shown promise in improving postoperative outcomes for cancer patients, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 19 years of age or older * Those who have been confirmed to have a malignant tumor of the thyroid gland by biopsy or imaging * Subjects who have undergone partial thyroidectomy or total resection within 1 month * Those who have agreed to the implementation of Chinese medicine treatment * The Eastern Cooperative Oncology Group(ECOG) performance status 0-3 * Those who understand the content of the study and agree to participate in the study Exclusion Criteria: * ○ When it is judged that other diseases other than cancer (dementia, cerebrovascular disease, severe organ failure, etc.) may have a significant effect on the decline of physical function * When it is judged that the life expectancy is less than 3 months and sufficient follow-up cannot be carried out * When emergency or major surgery or surgical intervention is required that takes precedence over postoperative treatment * Pregnant and lactating women * Other researchers who are judged to be unsuitable for research
Where this trial is running
Gyeonggi-do and 2 other locations
- Bundang Cha Hospital — Gyeonggi-do, South Korea (Recruiting)
- Ilsan Cha Hospital — Gyeonggi-do, South Korea (Recruiting)
- Gangnam Cha Hospital — Seoul, South Korea (Recruiting)
Study contacts
- Principal investigator: Jee Youg Lee — Ilsan Cha hospital
- Study coordinator: Jee Youg Lee
- Email: happiade@chamc.co.kr
- Phone: 082-31-782-3113
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.